nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—HTR1A—bipolar disorder	0.744	1	CbGaD
Dihydroergotamine—HTR1B—telencephalic ventricle—bipolar disorder	0.00879	0.151	CbGeAlD
Dihydroergotamine—HTR1D—telencephalic ventricle—bipolar disorder	0.00851	0.146	CbGeAlD
Dihydroergotamine—HTR1A—telencephalic ventricle—bipolar disorder	0.0071	0.122	CbGeAlD
Dihydroergotamine—CYP3A4—urine—bipolar disorder	0.00358	0.0613	CbGeAlD
Dihydroergotamine—HTR1A—blood plasma—bipolar disorder	0.00338	0.058	CbGeAlD
Dihydroergotamine—ADRA2A—blood plasma—bipolar disorder	0.00237	0.0406	CbGeAlD
Dihydroergotamine—HTR6—nervous system—bipolar disorder	0.00207	0.0354	CbGeAlD
Dihydroergotamine—Ergoloid mesylate—DRD1—bipolar disorder	0.00202	0.166	CrCbGaD
Dihydroergotamine—HTR2B—adrenal cortex—bipolar disorder	0.00192	0.0328	CbGeAlD
Dihydroergotamine—CYP3A4—blood plasma—bipolar disorder	0.00187	0.032	CbGeAlD
Dihydroergotamine—Bromocriptine—DRD5—bipolar disorder	0.00176	0.144	CrCbGaD
Dihydroergotamine—HTR6—brain—bipolar disorder	0.00158	0.0271	CbGeAlD
Dihydroergotamine—Ergoloid mesylate—DRD2—bipolar disorder	0.00142	0.117	CrCbGaD
Dihydroergotamine—HTR2B—thyroid gland—bipolar disorder	0.00133	0.0229	CbGeAlD
Dihydroergotamine—ABCB1—blood plasma—bipolar disorder	0.00132	0.0226	CbGeAlD
Dihydroergotamine—HTR1B—nervous system—bipolar disorder	0.00125	0.0214	CbGeAlD
Dihydroergotamine—HTR1D—nervous system—bipolar disorder	0.00121	0.0207	CbGeAlD
Dihydroergotamine—HTR2B—nervous system—bipolar disorder	0.00112	0.0192	CbGeAlD
Dihydroergotamine—HTR1A—nervous system—bipolar disorder	0.00101	0.0172	CbGeAlD
Dihydroergotamine—HTR1B—brain—bipolar disorder	0.000953	0.0163	CbGeAlD
Dihydroergotamine—HTR1A—cerebellum—bipolar disorder	0.000947	0.0162	CbGeAlD
Dihydroergotamine—HTR1D—brain—bipolar disorder	0.000922	0.0158	CbGeAlD
Dihydroergotamine—Bromocriptine—DRD4—bipolar disorder	0.000898	0.0737	CrCbGaD
Dihydroergotamine—HTR2B—brain—bipolar disorder	0.000858	0.0147	CbGeAlD
Dihydroergotamine—ADRA2A—thyroid gland—bipolar disorder	0.000838	0.0144	CbGeAlD
Dihydroergotamine—Bromocriptine—DRD3—bipolar disorder	0.000775	0.0636	CrCbGaD
Dihydroergotamine—HTR1A—brain—bipolar disorder	0.000769	0.0132	CbGeAlD
Dihydroergotamine—Bromocriptine—DRD1—bipolar disorder	0.00076	0.0624	CrCbGaD
Dihydroergotamine—ADRA2A—nervous system—bipolar disorder	0.000705	0.0121	CbGeAlD
Dihydroergotamine—Ergotamine—HTR2C—bipolar disorder	0.000675	0.0554	CrCbGaD
Dihydroergotamine—ABCB1—adrenal cortex—bipolar disorder	0.000671	0.0115	CbGeAlD
Dihydroergotamine—ADRA2A—cerebellum—bipolar disorder	0.000663	0.0114	CbGeAlD
Dihydroergotamine—Ergotamine—HTR1A—bipolar disorder	0.000655	0.0538	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR2C—bipolar disorder	0.00065	0.0534	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR1A—bipolar disorder	0.000631	0.0518	CrCbGaD
Dihydroergotamine—Ergotamine—DRD2—bipolar disorder	0.000556	0.0456	CrCbGaD
Dihydroergotamine—CYP3A4—nervous system—bipolar disorder	0.000555	0.00951	CbGeAlD
Dihydroergotamine—ADRA2A—brain—bipolar disorder	0.000539	0.00924	CbGeAlD
Dihydroergotamine—Bromocriptine—DRD2—bipolar disorder	0.000536	0.044	CrCbGaD
Dihydroergotamine—ABCB1—thyroid gland—bipolar disorder	0.000467	0.008	CbGeAlD
Dihydroergotamine—Ergotamine—HTR2A—bipolar disorder	0.00043	0.0353	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR2A—bipolar disorder	0.000414	0.034	CrCbGaD
Dihydroergotamine—ABCB1—nervous system—bipolar disorder	0.000393	0.00673	CbGeAlD
Dihydroergotamine—ABCB1—cerebellum—bipolar disorder	0.00037	0.00634	CbGeAlD
Dihydroergotamine—ABCB1—brain—bipolar disorder	0.0003	0.00515	CbGeAlD
Dihydroergotamine—HTR1A—Signaling by GPCR—DRD1—bipolar disorder	4.85e-05	0.000262	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR2C—bipolar disorder	4.85e-05	0.000262	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PDE4B—bipolar disorder	4.84e-05	0.000261	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TACR1—bipolar disorder	4.84e-05	0.000261	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TSHB—bipolar disorder	4.84e-05	0.000261	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ADM—bipolar disorder	4.83e-05	0.00026	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PDE4B—bipolar disorder	4.8e-05	0.000259	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TACR1—bipolar disorder	4.8e-05	0.000259	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TSHB—bipolar disorder	4.8e-05	0.000259	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—SLC5A3—bipolar disorder	4.78e-05	0.000258	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	4.78e-05	0.000258	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—IMPA1—bipolar disorder	4.77e-05	0.000257	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TSHB—bipolar disorder	4.77e-05	0.000257	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TACR1—bipolar disorder	4.77e-05	0.000257	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—PDE4B—bipolar disorder	4.77e-05	0.000257	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TRPC3—bipolar disorder	4.75e-05	0.000256	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—AKR1C4—bipolar disorder	4.75e-05	0.000256	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—ADCY2—bipolar disorder	4.73e-05	0.000255	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TSHB—bipolar disorder	4.7e-05	0.000254	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TACR1—bipolar disorder	4.7e-05	0.000254	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PDE4B—bipolar disorder	4.7e-05	0.000254	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—DRD3—bipolar disorder	4.7e-05	0.000253	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—DRD2—bipolar disorder	4.68e-05	0.000252	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—POMC—bipolar disorder	4.63e-05	0.00025	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—DRD4—bipolar disorder	4.56e-05	0.000246	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR2A—bipolar disorder	4.56e-05	0.000246	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ADM—bipolar disorder	4.53e-05	0.000245	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR2A—bipolar disorder	4.43e-05	0.000239	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TSHB—bipolar disorder	4.42e-05	0.000238	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PDE4B—bipolar disorder	4.42e-05	0.000238	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TACR1—bipolar disorder	4.42e-05	0.000238	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR2A—bipolar disorder	4.39e-05	0.000237	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—DGKH—bipolar disorder	4.37e-05	0.000236	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—IMPA2—bipolar disorder	4.35e-05	0.000235	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR1A—bipolar disorder	4.35e-05	0.000234	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HTR2A—bipolar disorder	4.3e-05	0.000232	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	4.29e-05	0.000232	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—TAC1—bipolar disorder	4.28e-05	0.000231	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	4.25e-05	0.000229	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—DRD1—bipolar disorder	4.2e-05	0.000226	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR2C—bipolar disorder	4.2e-05	0.000226	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	4.07e-05	0.000219	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NDUFV2—bipolar disorder	4.06e-05	0.000219	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR2A—bipolar disorder	4.04e-05	0.000218	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR2A—bipolar disorder	4.02e-05	0.000217	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR1A—bipolar disorder	4.01e-05	0.000216	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	4e-05	0.000216	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR2A—bipolar disorder	3.99e-05	0.000215	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR1A—bipolar disorder	3.98e-05	0.000215	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	3.95e-05	0.000213	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TAC1—bipolar disorder	3.95e-05	0.000213	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	3.95e-05	0.000213	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—AKR1C4—bipolar disorder	3.93e-05	0.000212	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	3.92e-05	0.000212	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TAC1—bipolar disorder	3.92e-05	0.000211	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HTR2A—bipolar disorder	3.91e-05	0.000211	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR1A—bipolar disorder	3.89e-05	0.00021	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	3.89e-05	0.00021	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2C—bipolar disorder	3.87e-05	0.000209	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—DRD1—bipolar disorder	3.87e-05	0.000209	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	3.85e-05	0.000208	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—DRD1—bipolar disorder	3.84e-05	0.000207	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2C—bipolar disorder	3.84e-05	0.000207	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TAC1—bipolar disorder	3.83e-05	0.000207	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	3.81e-05	0.000206	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	3.81e-05	0.000206	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NTRK2—bipolar disorder	3.76e-05	0.000203	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—DRD1—bipolar disorder	3.76e-05	0.000203	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2C—bipolar disorder	3.76e-05	0.000203	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—DRD3—bipolar disorder	3.75e-05	0.000202	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NTRK2—bipolar disorder	3.74e-05	0.000202	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—GSK3A—bipolar disorder	3.73e-05	0.000201	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—DRD3—bipolar disorder	3.72e-05	0.000201	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	3.71e-05	0.0002	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—GSK3A—bipolar disorder	3.7e-05	0.0002	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	3.69e-05	0.000199	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADM—bipolar disorder	3.68e-05	0.000198	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	3.68e-05	0.000198	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR2A—bipolar disorder	3.67e-05	0.000198	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NTRK2—bipolar disorder	3.66e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR1A—bipolar disorder	3.66e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—DRD3—bipolar disorder	3.64e-05	0.000197	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	3.64e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—DRD4—bipolar disorder	3.64e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—GSK3A—bipolar disorder	3.63e-05	0.000196	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—DRD4—bipolar disorder	3.61e-05	0.000195	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TAC1—bipolar disorder	3.6e-05	0.000194	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	3.58e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	3.58e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TACR1—bipolar disorder	3.58e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TSHB—bipolar disorder	3.58e-05	0.000193	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	3.54e-05	0.000191	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—DRD4—bipolar disorder	3.54e-05	0.000191	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—POMC—bipolar disorder	3.53e-05	0.000191	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—DRD1—bipolar disorder	3.53e-05	0.000191	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR2C—bipolar disorder	3.53e-05	0.000191	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NR1D1—bipolar disorder	3.53e-05	0.00019	CbGpPWpGaD
Dihydroergotamine—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	3.52e-05	0.00019	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—POMC—bipolar disorder	3.51e-05	0.000189	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CLOCK—bipolar disorder	3.46e-05	0.000186	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NTRK2—bipolar disorder	3.44e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—POMC—bipolar disorder	3.43e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—ADCY2—bipolar disorder	3.43e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—DRD3—bipolar disorder	3.42e-05	0.000185	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TCF7L2—bipolar disorder	3.41e-05	0.000184	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—GSK3A—bipolar disorder	3.41e-05	0.000184	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—ADCY2—bipolar disorder	3.4e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—DRD2—bipolar disorder	3.39e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TCF7L2—bipolar disorder	3.39e-05	0.000183	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—NCAN—bipolar disorder	3.37e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	3.37e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—TSHB—bipolar disorder	3.37e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—TPH2—bipolar disorder	3.37e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CACNB2—bipolar disorder	3.37e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—DRD2—bipolar disorder	3.36e-05	0.000182	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	3.34e-05	0.00018	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—ADCY2—bipolar disorder	3.33e-05	0.00018	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—DRD4—bipolar disorder	3.32e-05	0.000179	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TCF7L2—bipolar disorder	3.32e-05	0.000179	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—DPYD—bipolar disorder	3.31e-05	0.000179	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—SLC5A3—bipolar disorder	3.31e-05	0.000178	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—DRD2—bipolar disorder	3.29e-05	0.000178	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Biological oxidations—POMC—bipolar disorder	3.29e-05	0.000177	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	3.28e-05	0.000177	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—POMC—bipolar disorder	3.23e-05	0.000174	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—POMC—bipolar disorder	3.21e-05	0.000173	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—POMC—bipolar disorder	3.19e-05	0.000172	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—ADCY2—bipolar disorder	3.13e-05	0.000169	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—POMC—bipolar disorder	3.12e-05	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TCF7L2—bipolar disorder	3.12e-05	0.000168	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—DRD2—bipolar disorder	3.09e-05	0.000167	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CACNA1C—bipolar disorder	3.08e-05	0.000166	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NTRK1—bipolar disorder	3.07e-05	0.000166	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NTRK1—bipolar disorder	3.05e-05	0.000164	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	3.03e-05	0.000163	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	3e-05	0.000162	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—S100B—bipolar disorder	2.98e-05	0.000161	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NTRK1—bipolar disorder	2.98e-05	0.000161	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	2.97e-05	0.000161	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—S100B—bipolar disorder	2.96e-05	0.00016	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—IMPA1—bipolar disorder	2.94e-05	0.000159	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—POMC—bipolar disorder	2.93e-05	0.000158	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TAC1—bipolar disorder	2.92e-05	0.000158	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—S100B—bipolar disorder	2.9e-05	0.000156	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADM—bipolar disorder	2.89e-05	0.000156	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	2.86e-05	0.000155	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—DRD1—bipolar disorder	2.86e-05	0.000155	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	2.82e-05	0.000152	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	2.82e-05	0.000152	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	2.82e-05	0.000152	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NTRK1—bipolar disorder	2.8e-05	0.000151	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	2.79e-05	0.00015	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—DRD3—bipolar disorder	2.77e-05	0.00015	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	2.76e-05	0.000149	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—S100B—bipolar disorder	2.72e-05	0.000147	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—DRD4—bipolar disorder	2.69e-05	0.000145	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—SNAP25—bipolar disorder	2.69e-05	0.000145	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NRG1—bipolar disorder	2.63e-05	0.000142	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	2.62e-05	0.000141	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NRG1—bipolar disorder	2.61e-05	0.000141	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	2.57e-05	0.000139	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NRG1—bipolar disorder	2.56e-05	0.000138	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	2.54e-05	0.000137	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	2.53e-05	0.000136	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—DRD2—bipolar disorder	2.51e-05	0.000135	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NDUFV2—bipolar disorder	2.5e-05	0.000135	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—AKR1C4—bipolar disorder	2.42e-05	0.000131	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NRG1—bipolar disorder	2.4e-05	0.00013	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CLOCK—bipolar disorder	2.39e-05	0.000129	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—ADCY2—bipolar disorder	2.38e-05	0.000129	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—POMC—bipolar disorder	2.38e-05	0.000128	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2A—bipolar disorder	2.37e-05	0.000128	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2A—bipolar disorder	2.36e-05	0.000127	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	2.34e-05	0.000126	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	2.33e-05	0.000126	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—TSHB—bipolar disorder	2.33e-05	0.000126	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—TPH2—bipolar disorder	2.33e-05	0.000126	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CACNB2—bipolar disorder	2.33e-05	0.000126	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2A—bipolar disorder	2.31e-05	0.000124	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	2.3e-05	0.000124	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—DPYD—bipolar disorder	2.29e-05	0.000124	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	2.27e-05	0.000123	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	2.25e-05	0.000121	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	2.25e-05	0.000121	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—S100B—bipolar disorder	2.21e-05	0.000119	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	2.19e-05	0.000118	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	2.18e-05	0.000118	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NR1D1—bipolar disorder	2.17e-05	0.000117	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	2.17e-05	0.000117	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR2A—bipolar disorder	2.17e-05	0.000117	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CACNA1C—bipolar disorder	2.13e-05	0.000115	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	2.12e-05	0.000114	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—NCAN—bipolar disorder	2.08e-05	0.000112	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—PIK3C2A—bipolar disorder	2.08e-05	0.000112	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	2.06e-05	0.000111	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—COMT—bipolar disorder	2.04e-05	0.00011	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—SLC5A3—bipolar disorder	2.04e-05	0.00011	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—MAOA—bipolar disorder	2.03e-05	0.000109	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	1.99e-05	0.000108	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	1.99e-05	0.000107	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	1.97e-05	0.000106	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NRG1—bipolar disorder	1.95e-05	0.000105	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—GSK3B—bipolar disorder	1.91e-05	0.000103	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—GSK3B—bipolar disorder	1.9e-05	0.000102	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—POMC—bipolar disorder	1.9e-05	0.000102	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—INS—bipolar disorder	1.89e-05	0.000102	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—POMC—bipolar disorder	1.88e-05	0.000102	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—INS—bipolar disorder	1.87e-05	0.000101	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	1.87e-05	0.000101	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—SNAP25—bipolar disorder	1.86e-05	0.0001	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—GSK3B—bipolar disorder	1.86e-05	0.0001	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—POMC—bipolar disorder	1.84e-05	9.94e-05	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—INS—bipolar disorder	1.83e-05	9.89e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	1.79e-05	9.63e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	1.76e-05	9.48e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—GSK3B—bipolar disorder	1.74e-05	9.41e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	1.74e-05	9.37e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—POMC—bipolar disorder	1.73e-05	9.34e-05	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—INS—bipolar disorder	1.72e-05	9.29e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—MTHFR—bipolar disorder	1.65e-05	8.9e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—ADCY2—bipolar disorder	1.65e-05	8.89e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	1.53e-05	8.27e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CLOCK—bipolar disorder	1.47e-05	7.95e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—TSHB—bipolar disorder	1.44e-05	7.74e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—TPH2—bipolar disorder	1.44e-05	7.74e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CACNB2—bipolar disorder	1.44e-05	7.74e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	1.41e-05	7.63e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—DPYD—bipolar disorder	1.41e-05	7.62e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—COMT—bipolar disorder	1.41e-05	7.61e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—POMC—bipolar disorder	1.4e-05	7.57e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—MAOA—bipolar disorder	1.4e-05	7.56e-05	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—INS—bipolar disorder	1.4e-05	7.53e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	1.38e-05	7.45e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—POMC—bipolar disorder	1.32e-05	7.12e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CACNA1C—bipolar disorder	1.31e-05	7.08e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—INS—bipolar disorder	1.31e-05	7.08e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	1.28e-05	6.9e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—SNAP25—bipolar disorder	1.15e-05	6.19e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—MTHFR—bipolar disorder	1.14e-05	6.15e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	1.11e-05	6e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	1.1e-05	5.95e-05	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—INS—bipolar disorder	1.1e-05	5.92e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—ADCY2—bipolar disorder	1.02e-05	5.48e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—POMC—bipolar disorder	9.12e-06	4.92e-05	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—INS—bipolar disorder	9.07e-06	4.89e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—COMT—bipolar disorder	8.69e-06	4.69e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MAOA—bipolar disorder	8.63e-06	4.66e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—MTHFR—bipolar disorder	7.03e-06	3.79e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—POMC—bipolar disorder	5.62e-06	3.03e-05	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—INS—bipolar disorder	5.59e-06	3.02e-05	CbGpPWpGaD
